Molecular pathology of age-related macular degeneration

[1]  M. Brantley,et al.  Association of complement factor H and LOC387715 genotypes with response of exudative age-related macular degeneration to photodynamic therapy , 2009, Eye.

[2]  S. Ennis,et al.  Association between the SERPING1 gene and age-related macular degeneration: a two-stage case–control study , 2008, The Lancet.

[3]  G. Rivas,et al.  Complement Factor H Binds to Denatured Rather than to Native Pentameric C-reactive Protein* , 2008, Journal of Biological Chemistry.

[4]  E. Chew,et al.  Chlamydia pneumoniae infection, complement factor H variants and age-related macular degeneration , 2008, British Journal of Ophthalmology.

[5]  P. Mitchell,et al.  The HtrA1 promoter polymorphism, smoking, and age-related macular degeneration in multiple case-control samples. , 2008, Ophthalmology.

[6]  G. Parmigiani,et al.  Toll-like receptor 3 and geographic atrophy in age-related macular degeneration. , 2008, The New England journal of medicine.

[7]  R. Klein,et al.  Inflammation, complement factor h, and age-related macular degeneration: the Multi-ethnic Study of Atherosclerosis. , 2008, Ophthalmology.

[8]  J. Kaiser.  First Gene for Severe Dry Macular Degeneration , 2008, Science.

[9]  Ivana K. Kim,et al.  Alleles in the HtrA serine peptidase 1 gene alter the risk of neovascular age-related macular degeneration. , 2008, Ophthalmology.

[10]  S. Fisher,et al.  Age-related macular degeneration is associated with an unstable ARMS2 (LOC387715) mRNA , 2008, Nature Genetics.

[11]  C. Nordgaard,et al.  Mitochondrial proteomics of the retinal pigment epithelium at progressive stages of age-related macular degeneration. , 2008, Investigative ophthalmology & visual science.

[12]  L. Dauphinot,et al.  HtrA1-dependent proteolysis of TGF-β controls both neuronal maturation and developmental survival , 2008, Cell Death and Differentiation.

[13]  Thomas J. Lukas,et al.  The Aged Retinal Pigment Epithelium/Choroid: A Potential Substratum for the Pathogenesis of Age-Related Macular Degeneration , 2008, PloS one.

[14]  J. Hoh,et al.  HTRA1 variants in exudative age-related macular degeneration and interactions with smoking and CFH. , 2008, Investigative ophthalmology & visual science.

[15]  F. Tsai,et al.  Vascular endothelial growth factor gene polymorphisms in age-related macular degeneration. , 2008, American journal of ophthalmology.

[16]  J. Ott,et al.  CFH and LOC387715/ARMS2 genotypes and treatment with antioxidants and zinc for age-related macular degeneration. , 2008, Ophthalmology.

[17]  M. Tsoumakidou,et al.  Dendritic cells in chronic obstructive pulmonary disease: new players in an old game. , 2008, American journal of respiratory and critical care medicine.

[18]  E. Chew,et al.  Chlamydia Pneumoniae Infection, Complement Factor H Variant, and Age-Related Macular Degeneration (AMD) , 2008 .

[19]  C. McCarty,et al.  Gene-environment interaction in progression of AMD: the CFH gene, smoking and exposure to chronic infection. , 2008, Human molecular genetics.

[20]  S. Rodríguez de Córdoba,et al.  Genetic deficiency of complement factor H in a patient with age-related macular degeneration and membranoproliferative glomerulonephritis. , 2008, Molecular immunology.

[21]  M. Woodward,et al.  APOE genotype, ethnicity, and the risk of cerebral hemorrhage , 2008, Neurology.

[22]  R. J. Ross,et al.  Immunological protein expression profile in Ccl2/Cx3cr1 deficient mice with lesions similar to age-related macular degeneration. , 2008, Experimental eye research.

[23]  Katherine M. James,et al.  Toll-like receptor polymorphisms and age-related macular degeneration. , 2008, Investigative ophthalmology & visual science.

[24]  P. Mitchell,et al.  The LOC387715 polymorphism, inflammatory markers, smoking, and age-related macular degeneration. A population-based case-control study. , 2008, Ophthalmology.

[25]  Zigurts K. Majumdar,et al.  Ccl2/Cx3cr1-Deficient Mice: An Animal Model for Age-Related Macular Degeneration , 2008, Ophthalmic Research.

[26]  H. Stefánsson,et al.  Genetics of gene expression and its effect on disease , 2008, Nature.

[27]  J. Haines,et al.  Peripheral reticular pigmentary change is associated with complement factor H polymorphism (Y402H) in age-related macular degeneration. , 2008, Ophthalmology.

[28]  T. Hawn,et al.  Toll-like receptor polymorphisms and susceptibility to human disease. , 2008, Clinical science.

[29]  A. Luff,et al.  Interleukin-8 promoter polymorphism −251A/T is a risk factor for age-related macular degeneration , 2008, British Journal of Ophthalmology.

[30]  P. Bora,et al.  The role of complement in ocular pathology , 2008, Seminars in Immunopathology.

[31]  Chi-Chao Chan,et al.  Immunopathological aspects of age-related macular degeneration , 2008, Seminars in Immunopathology.

[32]  T. Wong,et al.  Familial aggregation of age-related macular degeneration in the Utah population , 2008, Vision Research.

[33]  F. Tsai,et al.  Interleukin gene polymorphisms in age-related macular degeneration. , 2008, Investigative ophthalmology & visual science.

[34]  P. Mitchell,et al.  Dietary antioxidants and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study. , 2008, Ophthalmology.

[35]  Ayyakkannu Manivannan,et al.  Age‐dependent accumulation of lipofuscin in perivascular and subretinal microglia in experimental mice , 2008, Aging cell.

[36]  T. Lehner.  Special regulatory T cell review: The resurgence of the concept of contrasuppression in immunoregulation , 2008, Immunology.

[37]  R. Guymer,et al.  A tag-single nucleotide polymorphisms approach to the vascular endothelial growth factor-A gene in age-related macular degeneration. , 2007, Molecular vision.

[38]  T. Salt,et al.  Complement factor H deficiency in aged mice causes retinal abnormalities and visual dysfunction , 2007, Proceedings of the National Academy of Sciences.

[39]  Gonçalo R. Abecasis,et al.  A variant of mitochondrial protein LOC387715/ARMS2, not HTRA1, is strongly associated with age-related macular degeneration , 2007, Proceedings of the National Academy of Sciences.

[40]  P. Debré,et al.  CX3CR1-dependent subretinal microglia cell accumulation is associated with cardinal features of age-related macular degeneration. , 2007, The Journal of clinical investigation.

[41]  F. Ferris,et al.  Age-related macular degeneration and the immune response: implications for therapy. , 2007, American journal of ophthalmology.

[42]  I. Deary,et al.  Complement C3 variant and the risk of age-related macular degeneration. , 2007, The New England journal of medicine.

[43]  J. Kowalak,et al.  Murine ccl2/cx3cr1 deficiency results in retinal lesions mimicking human age-related macular degeneration. , 2007, Investigative ophthalmology & visual science.

[44]  U. Schlötzer-Schrehardt,et al.  Defective complement control of factor H (Y402H) and FHL-1 in age-related macular degeneration. , 2007, Molecular immunology.

[45]  R. Kawaguchi,et al.  Biochemical analysis of a common human polymorphism associated with age-related macular degeneration. , 2007, Biochemistry.

[46]  K. Horie-Inoue,et al.  Association of the HTRA1 gene variant with age-related macular degeneration in the Japanese population , 2007, Journal of Human Genetics.

[47]  T. Langmann.  Microglia activation in retinal degeneration , 2007, Journal of leukocyte biology.

[48]  J. H. Kim,et al.  Human apolipoprotein E2 transgenic mice show lipid accumulation in retinal pigment epithelium and altered expression of VEGF and bFGF in the eyes. , 2007, Journal of microbiology and biotechnology.

[49]  D. Gibbs,et al.  Vascular Endothelial Growth Factor (VEGF) Polymorphisms and Their Association With Age-Related Macular Degeneration , 2007 .

[50]  A. Hofman,et al.  Polymorphisms in the Vascular Endothelial Growth Factor Gene and Risk of Aging Macula Disorder: The Rotterdam Study , 2007 .

[51]  P. Bernstein,et al.  HTRA1 Variant Confers Similar Risks to Geographic Atrophy and Neovascular Age-related Macular Degeneration , 2007, Cell cycle.

[52]  N. Pfeiffer,et al.  Analysis of IgG antibody patterns against retinal antigens and antibodies to α-crystallin, GFAP, and α-enolase in sera of patients with “wet” age-related macular degeneration , 2007, Graefe's Archive for Clinical and Experimental Ophthalmology.

[53]  B. Rosner,et al.  Association of CFH Y402H and LOC387715 A69S with progression of age-related macular degeneration. , 2007, JAMA.

[54]  Hongyu Zhao,et al.  Evidence for association between multiple complement pathway genes and AMD , 2007, Genetic epidemiology.

[55]  C. Nordgaard,et al.  Changes in select redox proteins of the retinal pigment epithelium in age-related macular degeneration. , 2007, American journal of ophthalmology.

[56]  S. Fekete,et al.  Association of apolipoprotein E polymorphism with age-related macular degeneration and Alzheimer's disease in south-western Hungary. , 2007, Ideggyogyaszati szemle.

[57]  Don H. Anderson,et al.  Y402H Polymorphism of Complement Factor H Affects Binding Affinity to C-Reactive Protein1 , 2007, The Journal of Immunology.

[58]  P. Mitchell,et al.  The LOC387715 polymorphism and age-related macular degeneration: replication in three case-control samples. , 2007, Investigative ophthalmology & visual science.

[59]  Jeffrey Wilusz,et al.  The highways and byways of mRNA decay , 2007, Nature Reviews Molecular Cell Biology.

[60]  Chi Pui Pang,et al.  HTRA1 promoter polymorphism in wet age-related macular degeneration. , 2007, Science.

[61]  R. Klein,et al.  Overview of Progress in the Epidemiology of Age-Related Macular Degeneration , 2007, Ophthalmic epidemiology.

[62]  Ke Liu,et al.  Association of complement factor H polymorphisms with exudative age-related macular degeneration. , 2006, Molecular vision.

[63]  K. Eng,et al.  Ranibizumab in neovascular age-related macular degeneration , 2006, Clinical interventions in aging.

[64]  M. Radeke,et al.  Individuals homozygous for the age-related macular degeneration risk-conferring variant of complement factor H have elevated levels of CRP in the choroid , 2006, Proceedings of the National Academy of Sciences.

[65]  N. Camp,et al.  A Variant of the HTRA1 Gene Increases Susceptibility to Age-Related Macular Degeneration , 2006, Science.

[66]  R. Klein,et al.  CFH, ELOVL4, PLEKHA1 and LOC387715 genes and susceptibility to age-related maculopathy: AREDS and CHS cohorts and meta-analyses. , 2006, Human molecular genetics.

[67]  J. Escardo,et al.  VEGF polymorphisms are associated with neovascular age-related macular degeneration. , 2006, Human molecular genetics.

[68]  P. Kaiser.  Antivascular endothelial growth factor agents and their development: therapeutic implications in ocular diseases. , 2006, American journal of ophthalmology.

[69]  L. Damico,et al.  DEVELOPMENT OF RANIBIZUMAB, AN ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR ANTIGEN BINDING FRAGMENT, AS THERAPY FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION , 2006, Retina.

[70]  B. Ning,et al.  An apolipoprotein E variant may protect against age‐related macular degeneration through cytokine regulation , 2006, Environmental and molecular mutagenesis.

[71]  T. Das,et al.  Analysis of CFH, TLR4, and APOE polymorphism in India suggests the Tyr402His variant of CFH to be a global marker for age-related macular degeneration. , 2006, Investigative ophthalmology & visual science.

[72]  R. Apte,et al.  Macrophages Inhibit Neovascularization in a Murine Model of Age-Related Macular Degeneration , 2006, PLoS medicine.

[73]  P. Mitchell,et al.  Retinal autoantibody profile in early age‐related macular degeneration: preliminary findings from the Blue Mountains Eye Study , 2006, Clinical & experimental ophthalmology.

[74]  J. Féher,et al.  Mitochondrial alterations of retinal pigment epithelium in age-related macular degeneration , 2006, Neurobiology of Aging.

[75]  Baitang Ning,et al.  Synergic effect of polymorphisms in ERCC6 5' flanking region and complement factor H on age-related macular degeneration predisposition. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[76]  J. Haines,et al.  Cigarette smoking strongly modifies the association of LOC387715 and age-related macular degeneration. , 2006, American journal of human genetics.

[77]  Steven Nusinowitz,et al.  Mouse models of age-related macular degeneration. , 2006, Experimental eye research.

[78]  G. Tikellis,et al.  Apolipoprotein (APOE) gene is associated with progression of age‐related macular degeneration (AMD) , 2006, Human mutation.

[79]  Tim Clausen,et al.  The Role of Human HtrA1 in Arthritic Disease* , 2006, Journal of Biological Chemistry.

[80]  A. Mizota,et al.  Complement factor H polymorphisms in Japanese population with age-related macular degeneration. , 2006, Molecular vision.

[81]  R. T. Smith,et al.  Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration , 2006, Nature Genetics.

[82]  C. Reilly,et al.  Proteomics of the retinal pigment epithelium reveals altered protein expression at progressive stages of age-related macular degeneration. , 2006, Investigative ophthalmology & visual science.

[83]  R. Klein,et al.  Apolipoprotein E gene and early age-related maculopathy: the Atherosclerosis Risk in Communities Study. , 2006, Ophthalmology.

[84]  G. Malek,et al.  Apolipoprotein E allele-dependent pathogenesis: a model for age-related retinal degeneration. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[85]  L. Paillard,et al.  AU-rich elements and associated factors: are there unifying principles? , 2006, Nucleic acids research.

[86]  Don H. Anderson,et al.  Age‐related macular degeneration—emerging pathogenetic and therapeutic concepts , 2006, Annals of medicine.

[87]  M. C. Donati,et al.  Retinal Angiomatous Proliferation: Association with Clinical and Angiographic Features , 2005, Ophthalmologica.

[88]  J. Gilbert,et al.  Joint effects of smoking history and APOE genotypes in age-related macular degeneration. , 2005, Molecular vision.

[89]  R. Klein,et al.  Genome-wide analyses demonstrate novel loci that predispose to drusen formation. , 2005, Investigative Ophthalmology and Visual Science.

[90]  G. Abecasis,et al.  Meta-analysis of genome scans of age-related macular degeneration. , 2005, Human molecular genetics.

[91]  Santa Jeremy Ono,et al.  Circulating anti‐retinal antibodies as immune markers in age‐related macular degeneration , 2005, Immunology.

[92]  W. Green,et al.  Detection of CX3CR1 single nucleotide polymorphism and expression on archived eyes with age-related macular degeneration. , 2005, Histology and histopathology.

[93]  Caitlin Smith.  Genomics: SNPs and human disease , 2005, Nature.

[94]  B. Godley,et al.  Blue Light Induces Mitochondrial DNA Damage and Free Radical Production in Epithelial Cells* , 2005, Journal of Biological Chemistry.

[95]  G. Abecasis,et al.  Toll-like receptor 4 variant D299G is associated with susceptibility to age-related macular degeneration. , 2005, Human molecular genetics.

[96]  J. McNeil,et al.  Exposure to Chlamydia pneumoniae infection and progression of age-related macular degeneration. , 2005, American journal of epidemiology.

[97]  Joan W. Miller,et al.  Identification of Chlamydia pneumoniae within human choroidal neovascular membranes secondary to age-related macular degeneration , 2005, Graefe's Archive for Clinical and Experimental Ophthalmology.

[98]  R. T. Smith,et al.  A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[99]  John D Lambris,et al.  Drusen complement components C3a and C5a promote choroidal neovascularization. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[100]  A. Edwards,et al.  Complement Factor H Polymorphism and Age-Related Macular Degeneration , 2005, Science.

[101]  J. Gilbert,et al.  Complement Factor H Variant Increases the Risk of Age-Related Macular Degeneration , 2005, Science.

[102]  J. Ott,et al.  Complement Factor H Polymorphism in Age-Related Macular Degeneration , 2005, Science.

[103]  K. Khabar,et al.  The AU-rich transcriptome: more than interferons and cytokines, and its role in disease. , 2005, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[104]  E. Gragoudas,et al.  Pegaptanib for neovascular age-related macular degeneration. , 2004, The New England journal of medicine.

[105]  Silvano Sozzani,et al.  The chemokine system in diverse forms of macrophage activation and polarization. , 2004, Trends in immunology.

[106]  A. Milam,et al.  Receptor for advanced glycation end products and age-related macular degeneration. , 2004, Investigative ophthalmology & visual science.

[107]  M. Dunbar,et al.  Retinal angiomatous proliferation: clinical characteristics and treatment options. , 2004, Optometry.

[108]  E. Chew,et al.  The involvement of sequence variation and expression of CX3CR1 in the pathogenesis of age‐related macular degeneration , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[109]  Howard R. Petty,et al.  Toll-Like Receptor 4 (TLR4) of Retinal Pigment Epithelial Cells Participates in Transmembrane Signaling in Response to Photoreceptor Outer Segments , 2004, The Journal of general physiology.

[110]  M. Kelley,et al.  Transient adenoviral N-methylpurine DNA glycosylase overexpression imparts chemotherapeutic sensitivity to human breast cancer cells. , 2004, Molecular cancer therapeutics.

[111]  J. Haines,et al.  Age-related maculopathy: a genomewide scan with continued evidence of susceptibility loci within the 1q31, 10q26, and 17q25 regions. , 2004, American journal of human genetics.

[112]  M. Smith-Wheelock,et al.  Association of apolipoprotein E alleles with susceptibility to age-related macular degeneration in a large cohort from a single center. , 2004, Investigative ophthalmology & visual science.

[113]  P. Kertes,et al.  POTENTIAL PUBLIC HEALTH IMPACT OF AGE-RELATED EYE DISEASE STUDY RESULTS: AREDS REPORT NO. 11 , 2004 .

[114]  K. Csaky,et al.  Clinicopathologic correlation of progressive fibrovascular proliferation associated with occult choroidal neovascularization in age-related macular degeneration. , 2004, Archives of ophthalmology.

[115]  P. Jong.  Prevalence of age-related macular degeneration in the United States. , 2004 .

[116]  M. Kawaichi,et al.  HtrA1 serine protease inhibits signaling mediated by Tgfβ family proteins , 2004, Development.

[117]  N. Rifai,et al.  Association between C-reactive protein and age-related macular degeneration. , 2004, JAMA.

[118]  A. Burlingame,et al.  Regulated expression of apolipoprotein E by human retinal pigment epithelial cells Published, JLR Papers in Press, November 1, 2003. DOI 10.1194/jlr.M300306-JLR200 , 2004, Journal of Lipid Research.

[119]  Alexander J. Rivest,et al.  Characterization of β amyloid assemblies in drusen: The deposits associated with aging and age-related macular degeneration , 2004 .

[120]  B. Rosner,et al.  Progression of age-related macular degeneration: association with dietary fat, transunsaturated fat, nuts, and fish intake. , 2003, Archives of ophthalmology.

[121]  Johanna M Seddon,et al.  Potential public health impact of Age-Related Eye Disease Study results: AREDS report no. 11. , 2003, Archives of ophthalmology.

[122]  Eiji Sakurai,et al.  An animal model of age-related macular degeneration in senescent Ccl-2- or Ccr-2-deficient mice , 2003, Nature Medicine.

[123]  T. Matise,et al.  Age-related macular degeneration--a genome scan in extended families. , 2003, American journal of human genetics.

[124]  K. Csaky,et al.  Macrophage depletion diminishes lesion size and severity in experimental choroidal neovascularization. , 2003, Investigative ophthalmology & visual science.

[125]  J. Ambati,et al.  Macrophage depletion inhibits experimental choroidal neovascularization. , 2003, Investigative ophthalmology & visual science.

[126]  T. Hisatomi,et al.  The critical role of ocular‐infiltrating macrophages in the development of choroidal neovascularization , 2003, Journal of leukocyte biology.

[127]  N. Ferrara,et al.  The biology of VEGF and its receptors , 2003, Nature Medicine.

[128]  J. Ott,et al.  Lack of an association of apolipoprotein E gene polymorphisms with familial age-related macular degeneration. , 2003, Archives of ophthalmology.

[129]  A. Milam,et al.  Activated microglia in human retinitis pigmentosa, late-onset retinal degeneration, and age-related macular degeneration. , 2003, Experimental eye research.

[130]  L. Pierro,et al.  Optical coherence tomography (OCT) in retinal angiomatous proliferation (RAP). , 2002, European journal of ophthalmology.

[131]  Masaru Miyagi,et al.  Drusen proteome analysis: An approach to the etiology of age-related macular degeneration , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[132]  R. Klein,et al.  Ten-year incidence and progression of age-related maculopathy: The Beaver Dam eye study. , 2002, Ophthalmology.

[133]  C. Southan,et al.  The HtrA family of proteases: implications for protein composition and cell fate. , 2002, Molecular cell.

[134]  Alexander J. Rivest,et al.  The Alzheimer's Aβ-peptide is deposited at sites of complement activation in pathologic deposits associated with aging and age-related macular degeneration , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[135]  M. Walport,et al.  Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H , 2002, Nature Genetics.

[136]  H. Grossniklaus,et al.  Macrophage and retinal pigment epithelium expression of angiogenic cytokines in choroidal neovascularization. , 2002, Molecular vision.

[137]  E. Wawrousek,et al.  Inflammatory Mediators in Uveitis: Differential Induction of Cytokines and Chemokines in Th1- Versus Th2-Mediated Ocular Inflammation , 2002, The Journal of Immunology.

[138]  J. Haines,et al.  A pooled case-control study of the apolipoprotein E (APOE) gene in age-related maculopathy , 2002, Ophthalmic genetics.

[139]  L. V. Johnson,et al.  Complement activation and inflammatory processes in Drusen formation and age related macular degeneration. , 2001, Experimental eye research.

[140]  Robert F. Mullins,et al.  An Integrated Hypothesis That Considers Drusen as Biomarkers of Immune-Mediated Processes at the RPE-Bruch's Membrane Interface in Aging and Age-Related Macular Degeneration , 2001, Progress in Retinal and Eye Research.

[141]  D. Turnbull,et al.  Mitochondrial abnormalities in ageing macular photoreceptors. , 2001, Investigative ophthalmology & visual science.

[142]  J. Slakter,et al.  RETINAL ANGIOMATOUS PROLIFERATION IN AGE–RELATED MACULAR DEGENERATION , 2001, Retina.

[143]  W. Willett,et al.  Dietary fat and risk for advanced age-related macular degeneration. , 2001, Archives of ophthalmology.

[144]  M. Kenney,et al.  Effects of cholesterol and apolipoprotein E on retinal abnormalities in ApoE-deficient mice. , 2001, Investigative ophthalmology & visual science.

[145]  D. Birch,et al.  Delayed dark-adaptation and lipofuscin accumulation in abcr+/- mice: implications for involvement of ABCR in age-related macular degeneration. , 2001, Investigative ophthalmology & visual science.

[146]  P. Penfold,et al.  Effects of triamcinolone acetonide on microglial morphology and quantitative expression of MHC‐II in exudative age‐related macular degeneration , 2001, Clinical & experimental ophthalmology.

[147]  G. Hageman,et al.  Structure and composition of drusen associated with glomerulonephritis: Implications for the role of complement activation in drusen biogenesis , 2001, Eye.

[148]  M. Walport,et al.  Complement. Second of two parts. , 2001, The New England journal of medicine.

[149]  M. Walport.  Complement. First of two parts. , 2001, The New England journal of medicine.

[150]  E. Rimm,et al.  Prospective study of dietary fat and the risk of age-related macular degeneration. , 2001, The American journal of clinical nutrition.

[151]  K. Bartz-Schmidt,et al.  Clinicopathological correlation of deep retinal vascular anomalous complex in age related macular degeneration , 2000, The British journal of ophthalmology.

[152]  D. Schwartz,et al.  TLR4 mutations are associated with endotoxin hyporesponsiveness in humans , 2000, Nature Genetics.

[153]  S. Russell,et al.  Drusen associated with aging and age‐related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[154]  L. V. Johnson,et al.  A potential role for immune complex pathogenesis in drusen formation. , 2000, Experimental eye research.

[155]  P. Mitchell,et al.  Dietary fat and fish intake and age-related maculopathy. , 2000, Archives of ophthalmology.

[156]  S. Russell,et al.  Location, substructure, and composition of basal laminar drusen compared with drusen associated with aging and age-related macular degeneration. , 2000, American journal of ophthalmology.

[157]  Greene Wr.  Histopathology of age-related macular degeneration. , 1999, Molecular vision.

[158]  J. Gilbert,et al.  Analysis of the Stargardt disease gene (ABCR) in age-related macular degeneration. , 1999, Ophthalmology.

[159]  M. Al-Ubaidi,et al.  Retina-derived microglial cells induce photoreceptor cell death in vitro , 1999, Brain Research.

[160]  D. Birch,et al.  Insights into the Function of Rim Protein in Photoreceptors and Etiology of Stargardt's Disease from the Phenotype in abcr Knockout Mice , 1999, Cell.

[161]  R. Frank,et al.  Antioxidant enzymes in the macular retinal pigment epithelium of eyes with neovascular age-related macular degeneration. , 1999, American journal of ophthalmology.

[162]  B. Godley,et al.  Hydrogen peroxide causes significant mitochondrial DNA damage in human RPE cells. , 1999, Experimental eye research.

[163]  C. Mold,et al.  Regulation of complement activation by C-reactive protein. , 1999, Immunopharmacology.

[164]  M. Killingsworth,et al.  Early drusen formation in the normal and aging eye and their relation to age related maculopathy: a clinicopathological study , 1999, The British journal of ophthalmology.

[165]  S. Russell,et al.  Vitronectin is a constituent of ocular drusen and the vitronectin gene is expressed in human retinal pigmented epithelial cells , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[166]  C. Curcio,et al.  Basal linear deposit and large drusen are specific for early age-related maculopathy. , 1999, Archives of ophthalmology.

[167]  C. Combadière,et al.  Gene cloning, RNA distribution, and functional expression of mCX3CR1, a mouse chemotactic receptor for the CX3C chemokine fractalkine. , 1998, Biochemical and biophysical research communications.

[168]  V. Sheffield,et al.  Allelic variation in ABCR associated with Stargardt disease but not age-related macular degeneration , 1998, Nature Genetics.

[169]  D. Patel,et al.  Fractalkine and CX3CR1 Mediate a Novel Mechanism of Leukocyte Capture, Firm Adhesion, and Activation under Physiologic Flow , 1998, The Journal of experimental medicine.

[170]  T. Matise,et al.  Age-related macular degeneration. Clinical features in a large family and linkage to chromosome 1q. , 1998, Archives of ophthalmology.

[171]  P. Mitchell,et al.  Family history and age-related maculopathy: the Blue Mountains Eye Study. , 1998, Australian and New Zealand journal of ophthalmology.

[172]  A. Hofman,et al.  Genetic association of apolipoprotein E with age-related macular degeneration. , 1998, American journal of human genetics.

[173]  A. Munnich,et al.  The γ e4 allele of the apolipoprotein E gene as a potential protective factor for exudative age-related macular degeneration , 1998 .

[174]  B. Rollins,et al.  Abnormalities in Monocyte Recruitment and Cytokine Expression in Monocyte Chemoattractant Protein 1–deficient Mice , 1998, The Journal of experimental medicine.

[175]  K. Ley,et al.  Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[176]  Wiklund Ra,et al.  First of two parts , 1997 .

[177]  B. Schreiber,et al.  Retinal Muller glia secrete apolipoproteins E and J which are efficiently assembled into lipoprotein particles. , 1997, Brain research. Molecular brain research.

[178]  J. Lupski,et al.  Corrigendum: A photoreceptor cell-specific ATP-binding transporter gene (ABCR) is mutated in recessive Stargardt macular dystrophy , 1997, Nature Genetics.

[179]  G. Travis,et al.  The photoreceptor rim protein is an ABC transporter encoded by the gene for recessive Stargardt's disease (ABCR) , 1997, FEBS letters.

[180]  J. Lupski,et al.  A photoreceptor cell-specific ATP-binding transporter gene (ABCR) is mutated in recessive Starqardt macular dystrophy , 1997, Nature Genetics.

[181]  E. Midena,et al.  Macular function impairment in eyes with early age-related macular degeneration. , 1997, Investigative ophthalmology & visual science.

[182]  P. D. de Jong,et al.  Increased expression of angiogenic growth factors in age-related maculopathy , 1997, The British journal of ophthalmology.

[183]  R. Klein,et al.  Dietary fat and age-related maculopathy. , 1995, Archives of ophthalmology.

[184]  Lawrence A. Yannuzzi,et al.  Dietary Carotenoids, Vitamins A, C, and E, and Advanced Age-Related Macular Degeneration , 1994 .

[185]  R Hiller,et al.  Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case-Control Study Group. , 1994, JAMA.

[186]  W. Green,et al.  Granulomatous reaction to Bruch's membrane in age-related macular degeneration. , 1994, Archives of ophthalmology.

[187]  W R Green,et al.  Age-related Macular Degeneration Histopathologic Studies: The 1992 Lorenz E. Zimmerman Lecture , 1993, Ophthalmology.

[188]  P Sternberg,et al.  Well-defined subfoveal choroidal neovascular membranes in age-related macular degeneration. , 1993, Ophthalmology.

[189]  P. Mathieson,et al.  Molecular analysis of C3 allotypes in patients with nephritic factor , 1993, Clinical and experimental immunology.

[190]  R. Strieter,et al.  Interleukin-8 as a macrophage-derived mediator of angiogenesis. , 1992, Science.

[191]  J. Lambris,et al.  Structural and functional analysis of the complement component factor H with the use of different enzymes and monoclonal antibodies to factor H. , 1985, The Biochemical journal.

[192]  M. Daly,et al.  Variation near complement factor I is associated with risk of advanced AMD , 2009, European Journal of Human Genetics.

[193]  J. Hutchinson.  Symmetrical central choroido-retinal disease occurring in senile persons , 2009 .

[194]  R. T. Smith,et al.  Comprehensive analysis of the candidate genes CCL2, CCR2, and TLR4 in age-related macular degeneration. , 2008, Investigative ophthalmology & visual science.

[195]  G. Hageman,et al.  Age-Related Macular Degeneration (AMD) , 2008 .

[196]  S. Teper,et al.  [VEGF in age-related macular degeneration. Part II. VEGF inhibitors use in age-related macular degeneration treatment]. , 2007, Klinika oczna.

[197]  H. Kretzschmar,et al.  ApoE Distribution and Family History in Genetic Prion Diseases in Germany , 2007, Journal of Molecular Neuroscience.

[198]  N. Pfeiffer,et al.  Analysis of IgG antibody patterns against retinal antigens and antibodies to alpha-crystallin, GFAP, and alpha-enolase in sera of patients with "wet" age-related macular degeneration. , 2007, Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie.

[199]  W. Green,et al.  Human HtrA1 in the archived eyes with age-related macular degeneration. , 2007, Transactions of the American Ophthalmological Society.

[200]  S. Wahl.  Transforming growth factor-beta: innately bipolar. , 2007, Current opinion in immunology.

[201]  S. Wahl.  Transforming growth factor-beta: innately bipolar. , 2007, Current opinion in immunology.

[202]  G. Lang,et al.  [Retinal angiomatous proliferation in age-related macular degeneration]. , 2006, Klinische Monatsblatter fur Augenheilkunde.

[203]  J. Gilbert,et al.  Functional candidate genes in age-related macular degeneration: significant association with VEGF, VLDLR, and LRP6. , 2006, Investigative ophthalmology & visual science.

[204]  P.T.V.M. de Jong,et al.  Mechanisms of disease: Age-related macular degeneration , 2006 .

[205]  A. Ramé.  [Age-related macular degeneration]. , 2006, Revue de l'infirmiere.

[206]  D. Weeks,et al.  Susceptibility genes for age-related maculopathy on chromosome 10q26. , 2005, American journal of human genetics.

[207]  E. Chew,et al.  Analysis of Hemicentin-1, hOgg1, and E-selectin single nucleotide polymorphisms in age-related macular degeneration. , 2005, Transactions of the American Ophthalmological Society.

[208]  Lars G Fritsche,et al.  Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk. , 2005, Human molecular genetics.

[209]  Benita J. O’Colmain,et al.  Prevalence of age-related macular degeneration in the United States. , 2004, Archives of ophthalmology.

[210]  Alexander J. Rivest,et al.  Characterization of beta amyloid assemblies in drusen: the deposits associated with aging and age-related macular degeneration. , 2004, Experimental eye research.

[211]  L. Pierro,et al.  Optical coherence tomography (OCT) angiomatous prolifieration (RAP) in retinal. , 2002, European journal of ophthalmology.

[212]  Jennifer I. Lim,et al.  A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. , 2001, Archives of ophthalmology.

[213]  A. Munnich,et al.  ABCR gene analysis in familial exudative age-related macular degeneration. , 2000, Investigative ophthalmology & visual science.

[214]  W. Green,et al.  Histopathology of age-related macular degeneration. , 1999, Molecular vision.

[215]  A. Munnich,et al.  The epsilon4 allele of the apolipoprotein E gene as a potential protective factor for exudative age-related macular degeneration. , 1998, American journal of ophthalmology.

[216]  M. Uyama,et al.  Expression of transforming growth factor-beta mRNA in experimental choroidal neovascularization. , 1997, Current eye research.

[217]  R. Klein,et al.  The five-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study. , 1997, Ophthalmology.

[218]  J. Lupski,et al.  Mutation of the Stargardt disease gene (ABCR) in age-related macular degeneration. , 1997, Science.